---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-26-000013"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:12:49.384943+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Salarius Pharmaceuticals renames to Decoy Therapeutics; ticker changes to DCOY effective Jan 8, 2026

## Summary
- Name change to Decoy Therapeutics Inc. and ticker symbol change from SLRX to DCOY effective January 8, 2026.
- No change to shares outstanding, shareholder rights, CUSIP number, or transfer agent.
- Focus on AI-enabled peptide-conjugate platform; lead antiviral program attracts BARDA interest.
- 2026 priorities: advance lead into clinic, expand pipeline, pursue partnerships, and strengthen capital structure.
- Company to launch new website decoytx.com for investor relations.

## SEC filing metadata
- accession: 0001615219-26-000013
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521926000013/0001615219-26-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521926000013/flks-20260108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-26-000013
- JSON: https://secwatch.observer/filing/0001615219-26-000013.json
- Plain text: https://secwatch.observer/filing/0001615219-26-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.